Osbonelle 150mg film-coated Tablets Malta - English - Medicines Authority

osbonelle 150mg film-coated tablets

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - ibandronic acid - film-coated tablet - ibandronic acid 150 mg - drugs for treatment of bone diseases

Zimycan 2.5mg/gram cutaneous paste Malta - English - Medicines Authority

zimycan 2.5mg/gram cutaneous paste

barrier therapeutics n.v. cipalstraat 3, b-2440 geel, belgium - miconazole nitrate - cutaneous paste - miconazole nitrate 2.5 mg - antifungals for dermatological use

Mitomycin medac 20 mg powder and solvent for intravesical solution Ireland - English - HPRA (Health Products Regulatory Authority)

mitomycin medac 20 mg powder and solvent for intravesical solution

medac gesellschaft fur klinische spezialpraparate mbh - mitomycin - pdr+solv/soln/intravesical use - 20 milligram(s) - other cytotoxic antibiotics; mitomycin

Non-Drowsy Sudapro Head Cold 200mg / 30mg Film-coated Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

non-drowsy sudapro head cold 200mg / 30mg film-coated tablets

mcneil healthcare (ireland) ltd - ibuprofen; pseudoephedrine hydrochloride - film-coated tablet - 200/30 milligram(s) - other cold preparations

Jentadueto European Union - English - EMA (European Medicines Agency)

jentadueto

boehringer ingelheim international gmbh - linagliptin, metformin - diabetes mellitus, type 2 - drugs used in diabetes, - treatment of adult patients with type-2 diabetes mellitus:jentadueto is indicated as an adjunct to diet and exercise to improve glycaemic control in adult patients inadequately controlled on their maximal tolerated dose of metformin alone, or those already being treated with the combination of linagliptin and metformin.jentadueto is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled on their maximal tolerated dose of metformin and a sulphonylurea.

Trajenta European Union - English - EMA (European Medicines Agency)

trajenta

boehringer ingelheim international gmbh - linagliptin - diabetes mellitus, type 2 - drugs used in diabetes - trajenta is indicated in the treatment of type 2 diabetes mellitus to improve glycaemic control in adults:as monotherapyin patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to intolerance, or contraindicated due to renal impairment.as combination therapyin combination with metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control.in combination with a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control.in combination with insulin with or without metformin, when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.

CITALOPRAM 10 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

citalopram 10 milligram film coated tablet

accord healthcare limited - citalopram hydrobromide - film coated tablet - 10 milligram - selective serotonin reuptake inhibitors

CITALOPRAM 20 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

citalopram 20 milligram film coated tablet

accord healthcare limited - citalopram hydrobromide - film coated tablet - 20 milligram - selective serotonin reuptake inhibitors